Physician profile
Brian Patrick Murphy
NPI 1376599506
$20,386.00
in general payments reported to CMS, 2019-2025
20 companies · $852 in 2025
The $852 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,973 · 2020: $844 · 2021: $2,508 · 2022: $497 · 2023: $5,717 · 2024: $6,995 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,102 · Consulting Fee: $4,290 · Food and Beverage: $1,671 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,102.35 |
| Consulting Fee | $4,290.00 |
| Food and Beverage | $1,671.28 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $14,506.44 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $3,623.06 | 2019-2023 | Accolade |
| Depuy Synthes Sales INC. | $1,057.22 | 2024 | Actis |
| Insight Medical Systems, INC. | $390.96 | 2023 | Arvis |
| Sanara Medtech INC. | $271.08 | 2025 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $124.76 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $86.08 | 2022-2025 | Iovera |
| Boston Scientific Corporation | $49.14 | 2023 | Watchman Flx |
| Medical Device Business Services, INC. | $44.20 | 2024 | |
| Janssen Biotech, INC. | $38.03 | 2024 | |
| Acorda Therapeutics, INC | $29.18 | 2021 | |
| Smith+Nephew, INC. | $22.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.68 | 2021 | |
| Supernus Pharmaceuticals, INC. | $22.04 | 2021 | |
| Biogen, INC. | $21.48 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $18.64 | 2021 | |
| Csl Behring | $15.43 | 2019 | |
| Medtronic, INC. | $15.40 | 2025 | Venaseal |
| Heraeus Medical, LLC. | $14.76 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.